Common blood pressure medicine blocks molecule that can trigger the disease
A drug commonly used to control high blood pressure may also help prevent the onset of Type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida (UF) in Gainesville.
The study was published online this week in the Journal of Clinical Investigation.
“This is the first personalized treatment for Type 1 diabetes prevention,” said Aaron Michels, MD, a researcher at the Barbara Davis Center for Childhood Diabetes and associate professor of medicine at CU Anschutz. “We made this discovery using a supercomputer, on the lab bench, in mice and in humans.”
The drug, methyldopa, has been used for over 50 years to treat high blood pressure in pregnant women and children. It is on the World Health Organization’s list of essential drugs.
But like many drugs used for one condition, Michels and his colleagues found it useful for something totally unrelated.
Some 60 percent of people at risk of getting Type 1 diabetes possess the DQ8 molecule which significantly increases the chance of getting the disease. The researchers believed that if they could block specifically the DQ8 molecule they could also block the onset of the disease.
“All drugs have off-target effects. If you take too much acetaminophen you can hurt your liver,” Michels said. “We took every FDA-approved small molecule drug and analyzed HLA-DQ8 binding through a supercomputer. We searched a thousand orientations for each drug to identify those that would fit within the DQ8 molecule binding groove.”
After running thousands of drugs through the supercomputer, they found that methyldopa not only blocked DQ8, but it didn’t harm the immune function of other cells like many immunosuppressant drugs do.
The research spanned 10 years and its efficacy was shown in mice and in 20 Type 1 diabetes patients who took part in a clinical trial at the Barbara Davis Center at the University of Colorado School of Medicine.
“We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes,” Michels said. “The goal with this drug is to delay or prevent the onset of the disease among those at risk.”
The drug is taken orally, three times a day.
Implications for treatment
Michels and UF Health researcher David Ostrov, PhD, hope this same approach of blocking specific molecules can be used in other diseases.
“This study has significant implications for treatment of diabetes and also other autoimmune diseases,” said Ostrov, associate professor of pathology, immunology and laboratory medicine in the UF College of Medicine and a member of the UF Health Cancer Center, Genetics Institute and Center for NeuroGenetics. “This study suggests that the same approach may be adapted to prevent autoimmune diseases such as rheumatoid arthritis, coeliac disease, multiple sclerosis, systemic lupus erythematosus and others.”
The next step will be a larger clinical trial sponsored by the National Institutes of Health in spring.
“With this drug, we can potentially prevent up to 60 percent of Type 1 diabetes in those at risk for the disease,” Michels said. “This is very significant development.”
The Latest on: Type 1 diabetes
via Google News
The Latest on: Type 1 diabetes
- A New Option For Type 1 Diabetes Treatment Shows Promising Pre-Clinical Resultson May 20, 2022 at 11:01 pm
Being diagnosed with type 1 diabetes today means a lifetime of insulin injections – as of yet, we don't have a simple one-time fix on hand. To date, each breakthrough promising a diabetes cure has ...
- Researchers Working Toward A Cure For Type 1 Diabeteson May 20, 2022 at 7:32 pm
Working on a cellular level, scientists are figuring out what causes Type 1 diabetes and then how to stop it. Snow Begins To Stick To Grass In Douglas County Friday EveningCBS4 Meteorologist Dave ...
- Colorado Researchers Working Toward A Cure For Type 1 Diabeteson May 20, 2022 at 2:45 pm
Some of the most advanced research in diabetes is being done right here in Colorado. The Barbara Davis Center is world renowned for the care and research of Type 1 diabetes. On the first floor at the ...
- All-Cause Mortality Falling Among People With Type 1 Diabeteson May 20, 2022 at 12:13 pm
In some cases, however, the rate of decline is no different than that of the general population, according to new research.
- Can You Take Ivermectin with Type 1 Diabetes?on May 20, 2022 at 1:00 am
Ivermectin is an oral, prescription medication that some have used for treating COVID-19 despite FDA warnings.
- Islet cell transplant program offers an effective treatment for patients with hard-to-control Type 1 diabeteson May 19, 2022 at 10:17 am
After 20 years of perfecting their technique, the team behind the largest islet cell transplant program in the world reports the procedure is a safe, reliable and life-changing treatment for people ...
- Unicorn Wranglers help close in on type 1 diabetes research with benefit concerton May 17, 2022 at 3:02 am
The benefit concert is designed to allow people to learn more about Type 1 diabetes and come together as a community ...
- Insulin Pumps, CGM, Help Empower Older Adults With Type 1 Diabetes to Exerciseon May 16, 2022 at 9:37 am
Older patients with type 1 diabetes (T1D) appear to benefit from insulin pumps and continuous glucose monitoring (CGM) when exercising, according to a new report. The study, based ...
- Modifying the body’s immune system to help treat Type 1 diabeteson May 13, 2022 at 12:06 pm
Scientists at University of Missouri collaborate with Harvard, Georgia Tech to develop a novel diabetes treatment involving transplanting pancreas cells that produce insulin.
via Bing News